This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Peters, G. A. Articles by Khan, S. A. Search for Related Content PubMed PubMed Citation Articles by Peters, G. A. Articles by Khan, S. A.

Estrogen Receptor Domains E and F: Role in Dimerization and Interaction with Coactivator RIP-140

Department of Cell Biology, Neurobiology, and Anatomy University of Cincinnati College of Medicine Cincinnati, Ohio 45267

We have used the yeast two-hybrid system to localize the ligand-dependent dimerization domain of the estrogen receptor- (ER) to region E in vivo. In this system, the cDNAs corresponding to the A–D, E, E/F, A–E (F), and full-length (wtER) domains of the human ER were each cloned into the yeast two-hybrid vectors GAL4 DB and GAL4 TA and expressed in different combinations in yeast harboring a GAL1-lacZ reporter. The reporter was used as a relative measure of the interaction between the ER domains, through reconstitution of GAL4 activity. We found that the interaction of E or E/F domains of the ER with full-length ER is estradiol dependent and estrogen responsive element independent, as measured by the reconstitution of GAL4 activity from GAL4-E domain-containing fusion protein interactions. In the presence of F domain, this activity is reduced 10-fold. The results suggest that sequences in the F domain are inhibitory to the dimerization signal that is present in the E region. We propose that the full-length ER contains intrinsic dimerization restraints contributed by regions outside domain E that are released upon binding hormone agonist. In addition, we have demonstrated that coactivator RIP140 is able to interact with the ER in vivo at the E domain of the receptor in the presence of estrogen. Yeast two-hybrid analysis shows that RIP140 does not homodimerize in the presence or absence of estrogens. We present evidence showing that the ER has the inherent ability to interact with RIP140 in the presence of antiestrogens, but sequences inherent in the ER itself that are present outside of the E domain compromise this ability.

This article has been cited by other articles:

				M. T. Sonoda, L. Martinez, P. Webb, M. S. Skaf, and I. Polikarpov Ligand Dissociation from Estrogen Receptor Is Mediated by Receptor Dimerization: Evidence from Molecular Dynamics Simulations Mol. Endocrinol., July 1, 2008; 22(7): 1565 - 1578. [Abstract] [Full Text] [PDF]

				M. M. Rytinki and J. J. Palvimo SUMOylation Modulates the Transcription Repressor Function of RIP140 J. Biol. Chem., April 25, 2008; 283(17): 11586 - 11595. [Abstract] [Full Text] [PDF]

				A. Koide, C. Zhao, M. Naganuma, J. Abrams, S. Deighton-Collins, D. F. Skafar, and S. Koide Identification of Regions within the F Domain of the Human Estrogen Receptor {alpha} that Are Important for Modulating Transactivation and Protein-Protein Interactions Mol. Endocrinol., April 1, 2007; 21(4): 829 - 842. [Abstract] [Full Text] [PDF]

				K. A. White, M. M. Yore, D. Deng, and M. J. Spinella Limiting Effects of RIP140 in Estrogen Signaling: POTENTIAL MEDIATION OF ANTI-ESTROGENIC EFFECTS OF RETINOIC ACID J. Biol. Chem., March 4, 2005; 280(9): 7829 - 7835. [Abstract] [Full Text] [PDF]

				K. Kim, N. Thu, B. Saville, and S. Safe Domains of Estrogen Receptor {alpha} (ER{alpha}) Required for ER{alpha}/Sp1-Mediated Activation of GC-Rich Promoters by Estrogens and Antiestrogens in Breast Cancer Cells Mol. Endocrinol., May 1, 2003; 17(5): 804 - 817. [Abstract] [Full Text] [PDF]

				F. Bonneton, D. Zelus, T. Iwema, M. Robinson-Rechavi, and V. Laudet Rapid Divergence of the Ecdysone Receptor in Diptera and Lepidoptera Suggests Coevolution Between ECR and USP-RXR Mol. Biol. Evol., April 1, 2003; 20(4): 541 - 553. [Abstract] [Full Text] [PDF]

				W.-C. Chou, V. Prokova, K. Shiraishi, U. Valcourt, A. Moustakas, M. Hadzopoulou-Cladaras, V. I. Zannis, and D. Kardassis Mechanism of a Transcriptional Cross Talk between Transforming Growth Factor-beta -regulated Smad3 and Smad4 Proteins and Orphan Nuclear Receptor Hepatocyte Nuclear Factor-4 Mol. Biol. Cell, March 1, 2003; 14(3): 1279 - 1294. [Abstract] [Full Text] [PDF]

				M. A. Loven, N. Muster, J. R. Yates, and A. M. Nardulli A Novel Estrogen Receptor {alpha}-Associated Protein, Template-Activating Factor I{beta}, Inhibits Acetylation and Transactivation Mol. Endocrinol., January 1, 2003; 17(1): 67 - 78. [Abstract] [Full Text] [PDF]

				A. Tamrazi, K. E. Carlson, J. R. Daniels, K. M. Hurth, and J. A Katzenellenbogen Estrogen Receptor Dimerization: Ligand Binding Regulates Dimer Affinity and DimerDissociation Rate Mol. Endocrinol., December 1, 2002; 16(12): 2706 - 2719. [Abstract] [Full Text] [PDF]

				J. A. Schwartz, L. Zhong, S. Deighton-Collins, C. Zhao, and D. F. Skafar Mutations Targeted to a Predicted Helix in the Extreme Carboxyl-terminal Region of the Human Estrogen Receptor-alpha Alter Its Response to Estradiol and 4-Hydroxytamoxifen J. Biol. Chem., April 5, 2002; 277(15): 13202 - 13209. [Abstract] [Full Text] [PDF]

				R. Métivier, F. G. Petit, Y. Valotaire, and F. Pakdel Function of N-Terminal Transactivation Domain of the Estrogen Receptor Requires a Potential {alpha}-Helical Structure and Is Negatively Regulated by the A Domain Mol. Endocrinol., November 1, 2000; 14(11): 1849 - 1871. [Abstract] [Full Text]

				J. Font de Mora and M. Brown AIB1 Is a Conduit for Kinase-Mediated Growth Factor Signaling to the Estrogen Receptor Mol. Cell. Biol., July 15, 2000; 20(14): 5041 - 5047. [Abstract] [Full Text]

				J. F. Couse and K. S. Korach Estrogen Receptor Null Mice: What Have We Learned and Where Will They Lead Us? Endocr. Rev., June 1, 1999; 20(3): 358 - 417. [Abstract] [Full Text]

				A. Warnmark, T. Almlof, J. Leers, J.-A. Gustafsson, and E. Treuter Differential Recruitment of the Mammalian Mediator Subunit TRAP220 by Estrogen Receptors ERalpha and ERbeta J. Biol. Chem., June 22, 2001; 276(26): 23397 - 23404. [Abstract] [Full Text] [PDF]

				M. A. Loven, V. S. Likhite, I. Choi, and A. M. Nardulli Estrogen Response Elements Alter Coactivator Recruitment through Allosteric Modulation of Estrogen Receptor beta Conformation J. Biol. Chem., November 21, 2001; 276(48): 45282 - 45288. [Abstract] [Full Text] [PDF]